Apple Inc. Stock Rises Friday, Still Underperforms Market

Abbvie Inc

Change company Symbol lookup

Select an option...

ABBV Abbvie Inc

FTAAU FTAC Athena Acquisition Corp

ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund

LGO Largo Inc

ONTO Onto Innovation Inc

OFED Oconee Federal Financial Corp

WKEY Wisekey International Holding AG

FPH Five Point Holdings LLC

FATE Fate Therapeutics Inc

MCD McDonald's Corp

Health Care : Biotechnology | Large Cap Value

Company profile

AbbVie Inc. is a research-based biopharmaceutical company, which is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta; aesthetics products that include Botox Cosmetic, Juvederm Collection and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products consists of Lumigan, Alphagan and Restasis; women's health products include Lo Loestrin, Orilissa and others; and other products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. Its products are sold to wholesalers, government agencies, health care facilities and independent retailers. It also discovers and develop antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled receptors (GPCRs).

Apple Inc. Stock Rises Friday, Still Underperforms Market

4:32 pm ET January 20, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Apple Inc. (AAPL) advanced 1.92% to $137.87 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 2.66% to 11,140.43 and the Dow Jones Industrial Average rising 1.00% to 33,375.49. This was the stock's second consecutive day of gains. Apple Inc. closed $41.74 short of its 52-week high ($179.61), which the company achieved on March 30th.

The stock underperformed when compared to some of its competitors Friday, as Microsoft Corp. (MSFT) rose 3.57% to $240.22, Alphabet Inc. Cl C (GOOGL) rose 5.72% to $99.28, and Alphabet Inc. Cl A (GOOGL) rose 5.34% to $98.02. Trading volume (79.4 M) eclipsed its 50-day average volume of 77.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 20, 2023.

(END) Dow Jones Newswires

January 20, 2023 16:32 ET (21:32 GMT)